07:14 AM EST, 11/12/2025 (MT Newswires) -- Loblaw Companies ( LBLCF ) said Wednesday that third-quarter adjusted earnings and revenue both rose, with both measures beating estimates.

Adjusted earnings increased 8% to $828 million or $0.69 per diluted share, from $767 million, or $0.62 per diluted share in the prior year period. The result was a cent above the consensus analyst forecast of $0.68, according to FactSet.

Revenue rose 4.6% to $19.35 billion, slightly above the $19.34 billion forecast, with both food and drug retail posting increases.

The company confirmed its 2025 guidance, but now expects full year adjusted earnings per share growth to edge up from high single-digits into the low double-digits. This excludes the impact of the 53rd week for 2025, which is forecast to benefit adjusted earnings per share growth by 2%, Loblaw ( LBLCF ) said.

Loblaw ( LBLCF ) also remains on track with its full-year plan to open 76 new stores and 100 new pharmacy clinics, and has opened 47 new stores and 55 new pharmacy clinics year-to-date.

A quarterly dividend of $0.14 per share will be paid on Dec. 30.